Stabilized antihistamine syrup
AssigneeSchering Corporation
InventorsFarah J. Munayyer, Frank Guazzo, Elliot I. Stupak, Imtiaz A. Chaudry, Joel A. Sequeira
Life of this patent
Estimating the term…
Abstract
An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.
Claims23
An antihistaminic syrup formulation containing about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid, including salts thereof.
An antihistaminic syrup formulation containing loratadine or descarboethoxyloratadine and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid or a salt thereof.
An antihistaminic syrup formulation containing loratadine and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid or a salt thereof.
An antihistaminic syrup formulation containing descarboethoxyloratadine and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid or a salt thereof.
Dependencies are inferred from the claim text.